HUP0004475A2 - Gyógyszerkészítmény - Google Patents

Gyógyszerkészítmény

Info

Publication number
HUP0004475A2
HUP0004475A2 HU0004475A HUP0004475A HUP0004475A2 HU P0004475 A2 HUP0004475 A2 HU P0004475A2 HU 0004475 A HU0004475 A HU 0004475A HU P0004475 A HUP0004475 A HU P0004475A HU P0004475 A2 HUP0004475 A2 HU P0004475A2
Authority
HU
Hungary
Prior art keywords
pharmaceutical composition
carmitine
aspartate
excipients
vascular
Prior art date
Application number
HU0004475A
Other languages
English (en)
Hungarian (hu)
Inventor
Tibor Keve
Original Assignee
GRADIENS Vegyitermékfejlesztż Kft.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GRADIENS Vegyitermékfejlesztż Kft. filed Critical GRADIENS Vegyitermékfejlesztż Kft.
Priority to HU0004475A priority Critical patent/HUP0004475A2/hu
Publication of HU0004475D0 publication Critical patent/HU0004475D0/hu
Publication of HUP0004475A2 publication Critical patent/HUP0004475A2/hu

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HU0004475A 2000-11-14 2000-11-14 Gyógyszerkészítmény HUP0004475A2 (hu)

Priority Applications (1)

Application Number Priority Date Filing Date Title
HU0004475A HUP0004475A2 (hu) 2000-11-14 2000-11-14 Gyógyszerkészítmény

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU0004475A HUP0004475A2 (hu) 2000-11-14 2000-11-14 Gyógyszerkészítmény

Publications (2)

Publication Number Publication Date
HU0004475D0 HU0004475D0 (cg-RX-API-DMAC7.html) 2001-01-29
HUP0004475A2 true HUP0004475A2 (hu) 2003-09-29

Family

ID=89978749

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0004475A HUP0004475A2 (hu) 2000-11-14 2000-11-14 Gyógyszerkészítmény

Country Status (1)

Country Link
HU (1) HUP0004475A2 (cg-RX-API-DMAC7.html)

Also Published As

Publication number Publication date
HU0004475D0 (cg-RX-API-DMAC7.html) 2001-01-29

Similar Documents

Publication Publication Date Title
CA2426703A1 (en) Therapeutic agents and methods of use thereof for the modulation of angiogenesis
IL139230A0 (en) Preparations for the application of anti-inflammatory, especially antiseptic agents and/or agents promoting the healing of wounds to the upper respiratory tract and/or the ear
BG106251A (en) Levodopa (carbidopa) entacapone pharmaceutical preparation
CA2427227A1 (en) Lactam compound
IL178072A (en) Use of monoesters of probucol or a pharmaceutically acceptable salt thereof for preparing medicaments for the treatment of cardiovascular and inflammatory disease
AU3632497A (en) Use of the chelating agent clioquinol for the manufacture of a pharmaceutical composition for the treatment of alzheimer's disease
WO1999004772A3 (en) Use of levobupivacaine
WO2002088100A3 (de) Deuterierte 3-piperidinopropiophenone sowie diese verbindungen enthaltende arzneimittel
MXPA03010761A (es) Combinaciones farmaceuticas.
GB9103764D0 (en) Compositions
NO994165L (no) Anvendelse av deskarboetoksyloratadin for fremstilling av et medikament for behandling av urininkontinens, reisesyke og svimmelhet
WO2000072823A8 (en) Preparations for the application of anti-inflammatory agents
CA2389032A1 (en) Preventive or therapeutic agents for inflammatory diseases of intestine
MXPA02006511A (es) Complejo que comprende factor inhibidor de osteoclastogenesis y polisacarido.
CA2340734A1 (en) Optically active pyridyl-4h-1,2,4-oxadiazine derivative and its use in the treatment of vascular diseases
AU2173101A (en) Use of carboxy compounds such as 2(4-acetoxyphenyl)-2-chloro-N-methyl-ethylammonium chloride as anti-inflammatory agents
MXPA02011533A (es) Nuevas formulaciones de alfa-2,4-disulfofenil-n-terc-butilnitrona.
MXPA03003980A (es) Uso de melagatran para la elaboracion de un medicamento para el tratamiento de transtornos isquemicos.
HUP0004475A2 (hu) Gyógyszerkészítmény
BG106151A (en) Pharmaceutical complex
AP2001002119A0 (en) Sertraline oral concentrate.
WO2002036105A3 (en) Use of cortisol-sequestering agents for the treatment of hypercortisolaemia related disorders
IL160486A0 (en) Citalopram for the treatment of elevated blood pressure
UA41326C2 (uk) Фармацевтична композиція для профілактики або лікування вірусних захворювань, засіб для профілактики або лікування вірусних захворювань
WO2002094377A3 (de) Physiologisch verträgliche kalium- und magnesiumsalze enthaltendes pharmazeutisches präparat und verwendung davon zur therapie von qt-zeitverlängerungen